Sulforaphane
Sulforaphane (SFN) · also known as Broccoli seed extract, Sulforaphane, Glucoraphanin + Myrosinase
Sulforaphane is a classic inducer of the Nrf2 pathway, and randomized human trials have shown increases in its target enzyme NQO1. Human evidence for effects on HDAC and NF-κB is weaker, and those effects are brief and inconsistent.
Clinical uses and human evidence
Blood sugar and insulin resistance
Studies (2)
- Dwibedi 2025 · Nat Microbiol · RCT · n=89 — Effect of broccoli sprout extract and baseline gut microbiota on fasting blood glucose in prediabetes: a randomized, placebo-controlled trial
- Axelsson 2017 · Sci Transl Med · RCT · n=97 — Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
Fatty liver and liver enzymes
Mechanisms of action
Nrf2/ARE activation of endogenous antioxidant enzymes
Sulforaphane is a classic inducer of the Nrf2 pathway and can upregulate Nrf2 target genes. In one randomized double-blind human trial, NQO1 rose in nasal lavage cells of smokers. The size of the response varies with tissue, dose and formulation, and not everyone can be expected to respond equally.
Epigenetic inhibition of histone deacetylases (HDACs)
Sulforaphane metabolites can inhibit HDAC in vitro. A small number of human studies found that HDAC activity in monocytes dropped briefly after eating broccoli sprouts. But the dose-response is unclear, as are the duration of the effect and its subtype selectivity.
Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
In experimental models, sulforaphane can reduce NF-κB binding to DNA. This may be related to cysteine modification of p65. The specific modification sites in humans have not been confirmed, and reliable pathway inhibition has not been directly measured after usual oral doses.